Christian Jobin

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.

The microbiome and cancer.

Epithelial cell-specific MyD88 signaling mediates ischemia/reperfusion-induced intestinal injury independent of microbial status.

Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Commensal microbiota stimulate systemic neutrophil migration through induction of serum amyloid A.

Gut commensal bacteria and regional Wnt gene expression in the proximal versus distal colon.

GPR109a: the missing link between microbiome and good health?

Chemotherapy, immunity and microbiota--a new triumvirate?

Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish.

Do bugs define cancer geography?

Nucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.

Chronic ethanol feeding modulates inflammatory mediators, activation of nuclear factor-κB, and responsiveness to endotoxin in murine Kupffer cells and circulating leukocytes.

Protective mucosal immunity mediated by epithelial CD1d and IL-10.

From promotion to management: the wide impact of bacteria on cancer and its treatment.

Fusobacterium and Enterobacteriaceae: important players for CRC?

Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite?

Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer.

The microbiota protects against ischemia/reperfusion-induced intestinal injury through nucleotide-binding oligomerization domain-containing protein 2 (NOD2) signaling.

Microbial imbalance and intestinal pathologies: connections and contributions.

Bugs and food: a recipe for cancer?

Microbial activities and intestinal homeostasis: A delicate balance between health and disease.

Professor Arlette Darfeuille-Michaud: the discovery of adherent-invasive Escherichia coli.

Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt.

Glass Microparticulate Ingestion: An Unusual and Difficult-to-Diagnose Cause of Chronic Abdominal Pain.

The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention.

Differential Relevance of NF-κB and JNK in the Pathophysiology of Hemorrhage/Resususcitation-Induced Liver Injury after Chronic Ethanol Feeding.

Microbiota and host immune responses: a love-hate relationship.

The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?

SCFAs Take a Toll En Route to Metabolic Syndrome.

Intestinal microbiota in inflammatory bowel disease and carcinogenesis: Implication for therapeutics.

The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.

Gut Microbiota and a Selectively Bred Taste Phenotype: A Novel Model of Microbiome-Behavior Relationships.

Microbiota as a mediator of cancer progression and therapy.

Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.

Human Intestinal Microbiota and Colorectal Cancer: Moving Beyond Associative Studies.

Precision medicine using microbiota.

Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice.

Bcl11b is essential for licensing Th2 differentiation during helminth infection and allergic asthma.

Microbial networking in cancer: when two toxins collide.

Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.

Microbial dysbiosis associated with impaired intestinal Na/H exchange accelerates and exacerbates colitis in ex-germ free mice.

Publisher Correction: Bcl11b is essential for licensing Th2 differentiation during helminth infection and allergic asthma.

Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant Isolate.

International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis.

Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection.

Microbiota in pancreatic health and disease: the next frontier in microbiome research.

Human Colon Mucosal Biofilms and Murine Host Communicate via Altered mRNA and microRNA Expression during Cancer.

Gut microbiota maturation during early human life induces enterocyte proliferation via microbial metabolites.

Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation.

Far reach of in cancer metastasis.

Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut.

Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer.

Microbiota phylogenic analysis revealed decreased abundance of Faecalibacterium prausnitzii, an anti-inflammatory commensal bacterium, in patients with chronic graft-versus-host disease.

Bacteria break barrier to promote metastasis.

The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.

Microbiota in mesenteric adipose tissue from Crohn's disease promote colitis in mice.

Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome.

Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort.

Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells.

Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival.

Skin microbiome sampling in the preterm neonate.

Non-pathogenic microbiota accelerate age-related CpG Island methylation in colonic mucosa.

Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer.

Intestinal bacteria and colorectal cancer: etiology and treatment.

Western diet influences on microbiome and carcinogenesis.

The microbial genotoxin colibactin exacerbates mismatch repair mutations in colorectal tumors.

Antibiotic-Induced Gut Microbiota Dysbiosis Modulates Host Transcriptome and mA Epitranscriptome via Bile Acid Metabolism.

Correlation between intestinal microbiota and urolithin metabolism in a human walnut dietary intervention.

Campylobacter jejuni-derived cytolethal distending toxin promotes colorectal cancer metastasis.

Genome-scale CRISPR/Cas9 screening reveals the role of in colibactin-mediated cell cycle arrest.